Clinical Trial Update: Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC [Phase 3]

View source ↗

Summary

Phase 3 infant safety and immunogenicity trial of MVA-BN in the Democratic Republic of Congo is active not recruiting for mpox vaccination in infants and childr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mpox

Drugs mentioned

• MVA-BN (Modified vaccinia Ankara Bavarian Nordic)

Snippet

Sponsor: Jean-Pierre Van geertruyden | Conditions: Mpox (Monkeypox), Vaccination | Phase 3 | Status: ACTIVE_NOT_RECRUITING